Fig. 1: Baseline Normalized Expression Levels of GSK3β, CRMP1, AKT1 and PKCein Patients with Bipolar Disorder Compared to Controls. | Translational Psychiatry

Fig. 1: Baseline Normalized Expression Levels of GSK3β, CRMP1, AKT1 and PKCein Patients with Bipolar Disorder Compared to Controls.

From: Lithium-associated transcriptional regulation of CRMP1 in patient-derived olfactory neurons and symptom changes in bipolar disorder

Fig. 1

Normalized expression levels of GSK3β, CRMP1, AKT1 and PKCein bipolar subjects compared to controls. GAPDH was used for an internal control for normalization of expression levels of these candidate genes. Significant differences (P < 0.02) were observed in the expression levels of GSK3β and CRMP1 in symptomatic bipolar subjects compared to controls

Back to article page